<DOC>
	<DOC>NCT02363348</DOC>
	<brief_summary>Randomized double-blind controled clinical trial to assess the efficacy and safety of L-arginine to prevent preeclampsia. applied to pregnant women with risk factors for preeclampsia. the main result was the development of preeclampsia as well as side effects to taking l arginine besides perinatal outcomes</brief_summary>
	<brief_title>Efficacy and Safety of L Arginine to Prevent Preeclampsia</brief_title>
	<detailed_description>Two groups were formed. one received L arginine 3 grams orally at day from the 20th week of pregnancy. the other group received placebo. Each three weeks were evaluated in search of high blood pressure and proteinuria. The follow-up was until the end of pregnancy and two weeks after this</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>one or more risk factors for developing preeclampsia (nulliparous, previous history of preeclampsia, chronic hypertension, BMI â‰¥30) pregnant women carriers of chronic renal failure pre gestational diabetes multiple pregnancy and were removed for some reason they received medication that would interfere with the interpretation of results (aspirin)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>L arginine</keyword>
	<keyword>Preeclampsia</keyword>
</DOC>